Search clinical trials for: Itacitinib (INCB039110)
Total 57 results
-
Incyte CorporationCompletedRheumatoid ArthritisUnited States, Puerto Rico
-
Incyte CorporationTerminatedBronchiolitis Obliterans SyndromeUnited States, Belgium, Canada
-
Incyte CorporationCompletedPolycythemia Vera | Myelofibrosis | ThrombocythemiaSpain, United States, Germany, Austria, Belgium, Italy, Poland
-
Imperial College LondonIncyte Biosciences UK LtdActive, not recruitingAdvanced Hepatocellular CarcinomaUnited Kingdom
-
Incyte CorporationAvailableSTAT1 Gain-of-Function Disease
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)Canada, United States, Australia
-
Incyte CorporationActive, not recruitingB-cell MalignanciesUnited States
-
Incyte CorporationActive, not recruitingChronic Graft Versus Host Disease | Myelofibrosis | Postlung Transplant (Bronchiolitis Obliterans)United States, Spain, Italy, Germany, Belgium, Austria, Israel, Canada, Greece
-
M.D. Anderson Cancer CenterActive, not recruitingBronchiolitis ObliteransUnited States
-
Incyte CorporationCompletedPlaque PsoriasisUnited States, Canada
-
Incyte CorporationTerminatedSolid TumorsUnited States
-
Incyte CorporationTerminatedRefractory Hodgkin Lymphoma | Recurrent Adult Hodgkin's Lymphoma
-
John LevineCompletedGVHD | Low Risk Acute Graft-versus-host Disease | Graft-versus-host-diseaseUnited States
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Netherlands, Austria
-
University of UtahIncyte CorporationTerminatedChronic Graft-versus-host-diseaseUnited States
-
SCRI Development Innovations, LLCIncyte CorporationTerminatedChronic Graft-versus-host-diseaseUnited States
-
Incyte CorporationWithdrawnModerate to Severe Ulcerative Colitis
-
Incyte CorporationCompleted
-
Fred Hutchinson Cancer CenterIncyte CorporationActive, not recruitingRefractory Soft Tissue Sarcoma | Metastatic Leiomyosarcoma | Metastatic Synovial Sarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Advanced Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma | Advanced Synovial Sarcoma | Metastatic Chondrosarcoma | Advanced Leiomyosarcoma | Metastatic Myxoid... and other conditionsUnited States
-
Incyte CorporationCompletedMelanoma | Breast Cancer | Head and Neck Cancer | Pancreatic Cancer | Lung Cancer | Endometrial Cancer | Solid Tumors | Renal Cell Carcinoma (RCC) | Colorectal Cancer (CRC) | UC (Urothelial Cancer) | MMR-deficient TumorsUnited States
-
Incyte CorporationCompletedAcute Graft-versus-host DiseaseJapan
-
Incyte CorporationAstraZenecaActive, not recruitingLung CancerUnited States, Korea, Republic of, Spain, Taiwan
-
Incyte CorporationCompleted
-
University of PennsylvaniaTerminatedNon Small Cell Lung CancerUnited States
-
Incyte CorporationTerminatedNSCLC (Non-small Cell Lung Carcinoma)United States
-
Massachusetts General HospitalIncyte CorporationTerminated
-
Incyte CorporationWithdrawnSolid Tumors and Hematologic Malignancy | NSCLC (Non-small Cell Lung Carcinoma)United States
-
Washington University School of MedicineWithdrawn
-
Incyte CorporationTerminatedHematologic MalignanciesUnited States, Spain, France, Italy
-
Incyte CorporationCompletedCytokine Release SyndromeUnited States
-
University of PennsylvaniaActive, not recruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingSystemic SclerosisFrance
-
Incyte CorporationRecruitingB-Cell MalignanciesUnited States, Spain, Belgium, Japan, Poland, Italy, France, United Kingdom, Israel, Turkey, Norway, Korea, Republic of, Czechia, Sweden, Austria, Hungary, Denmark
-
Columbia UniversityIncyte CorporationTerminatedGraft Vs Host Disease | Steroid Refractory GVHDUnited States
-
Michael SavonaIncyte Corporation; Astex Pharmaceuticals, Inc.; TheradexRecruiting
-
Incyte CorporationNo longer available
-
Assistance Publique - Hôpitaux de ParisIncyte CorporationRecruitingAdults Patients Having Non Severe HLHFrance
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States
-
M.D. Anderson Cancer CenterActive, not recruitingRecurrent T-Cell Prolymphocytic Leukemia | T-Cell Prolymphocytic LeukemiaUnited States
-
Incyte CorporationTerminatedAcute Graft-versus-host DiseaseUnited States, Spain, France, Italy, United Kingdom, Germany
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Incyte CorporationRecruitingMyelodysplastic Syndromes | Myeloproliferative Disorders | Multiple Myeloma | Plasma Cell Leukemia | CML | T-cell Prolymphocytic Leukemia | Leukemia, Acute | Myelomonocytic Leukemia, ChronicUnited States
-
Incyte CorporationCompletedPancreatic Cancer | Solid TumorsUnited States
-
Digestive & Liver Disease SpecialistsAstraZenecaCompleted
-
Douglas JohnsonIncyte CorporationRecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
Incyte CorporationTerminatedChronic Graft-versus-host DiseaseUnited States, Spain, France, Canada, Israel, United Kingdom, Germany, Italy, Denmark, Sweden, Finland, Belgium, Poland, Greece, Austria, Switzerland
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States, Spain, Belgium, France, Italy, Korea, Republic of, Finland, United Kingdom, Germany, Israel, Switzerland, Austria, Australia, Czechia, Greece, New Zealand, Poland, Portugal, Taiwan
-
Washington University School of MedicineNational Cancer Institute (NCI); Incyte Corporation; American Society of HematologyActive, not recruitingMyelodysplastic Syndromes | Hodgkin Disease | Non-Hodgkin Lymphoma | Acute Lymphocytic Leukemia | Acute Myelogenous LeukemiaUnited States
-
Cliniques universitaires Saint-Luc- Université...NovartisTerminatedCarcinoma Transitional CellBelgium, Luxembourg
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationRecruitingDiffuse Large B Cell LymphomaUnited States
-
Vanderbilt University Medical CenterVeloxis PharmaceuticalsRecruitingRenal TransplantUnited States